º¬Ðß²ÝÊÓÆµ

+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
Parathyroid Hormone Market Report 2026 - Product Thumbnail Image

Parathyroid Hormone Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Hormone Therapy Market Report 2026 - Product Thumbnail Image

Hormone Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Marine Enzymes Market 2024-2028 - Product Thumbnail Image

Marine Enzymes Market 2024-2028

  • Report
  • November 2023
  • 179 Pages
  • Global
From
Prescription Drugs Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Prescription Drugs Market - Forecasts from 2025 to 2030

  • Report
  • December 2024
  • 155 Pages
  • Global
From
From
From
From
From
Bioengineered Protein Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bioengineered Protein Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 196 Pages
  • Global
From
From
From
From
From
Acetyl-CoA Carboxylase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Acetyl-CoA Carboxylase Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator